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XRCC3241 POLYMORPHISM INFLUENCE ON GENOTOXICITY BIOMARKERS 
FREQUENCY IN WORKERS OCCUPATIONALLY EXPOSED TO FORMALDEHYDE
Formaldehyde (FA) is ubiquitous in the environment and is a
chemical agent that possesses high reactivity. Occupational
exposure to FA has been shown to induce nasopharyngeal
cancer and has been classified as carcinogenic to humans
(group 1) on the basis of sufficient evidence in humans and
sufficient evidence in experimental animals. The exposure to
this substance is epidemiologically linked to cancer and nuclear
changes detected by the cytokinesis-block micronucleus test
(CBMN). This method is extensively used in molecular
epidemiology, since it determines several biomarkers of
genotoxicity, such as micronucleus (biomarkers of
chromosomes breakage or loss), nucleoplasmic bridges
(biomarker of chromosome rearrangement, poor repair and / or
telomeres fusion) and nuclear buds (biomarker of elimination of
amplified DNA).
The gene X-ray repair cross-complementing group 3 (XRCC3) is
involved in homologous recombination repair of cross-links and
chromosomal double-strand breaks and at least one
polymorphism has been reported in codon 241, a substitution of
a methionine for a threonine.
Introduction Aim of the Study
Determine whether there is an in vivo association between
genetic polymorphism of XRCC3 and the frequency of
genotoxicity biomarkers – MN, NPB, NBUD and MN in buccal
cells, in occupationally workers exposed to formaldehyde.
Conclusions
The exposed workers carrying the Thr/Met XRCC3241 genotype were found to have higher MN mean than Met/Met and Thr/Thr
XRCC3 241 genotypes. Moreover, the values were higher when compared with their control counterparts. Binary logistic regression
analysis indicated that the exposure to formaldehyde was an important variable affecting the genotoxic response (p<0.001), but the
polymorphisms of XRCC3 at codon 241 were not found statistically significant with exception to NBUD (p<0.05). Understanding the
complexity of the relationships between exposure, DNA repair and genotoxicity biomarkers frequencies probably require larger scale
studies and complementary biomarkers. Chromosomal instability has been associated to XRCC3 gene mutation and other genes
involved in repair. Manifold studies suggest a direct role of XRCC3 Thr241Met polymorphism maybe associated, but not significant,
to a reduce capacity of DNA repair. This study was verified that carriers of Thr241Met polymorphism have higher means of
genotoxicity biomarkers in exposed workers.
We compare a sample of 52 workers exposed to FA in
pathological anatomy laboratories with 82 controls, in order to
investigate whether exposure to FA and of genetic
polymorphism of XRCC3 is associated with the frequency of the
genotoxicity biomarkers in study. The evaluation of genotoxic
effects was measured by CBMN. All samples were coded and
analysed under blind conditions and the criterion of scoring the
cells was the same as the described in The Human
MicroNucleus Project. DNA was isolated from PBL and the
XRCC3 241 genotype study was performed by Real Time PCR,
using the iCycler iQ® Multicolor Real-Time PCR Detection
System (BIO-RAD).
Methodology
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Groups XRCC3 N Mean MN 
lymphocytes 
± S.E.
Mean 
NPB± S.E.
Mean 
NBUD±
S.E.
Mean MN buccal 
cells ± S.E.
Exposed Met/Met 13 2.92±0.930
(0-12)
2.00±1.138
(0-15)
0.38±0.180
(0-2)
1.00±0.707
(0-9)
Thr/Met 22 5.05±0.979
(0-14)
3.91±0.840
(0-13)
1.50±0.334
(880-2)
1.05±0.381
(0-5)
Thr/Thr 17 3.88±0.848
(0-12)
2.82±0.944
(0-13)
0.24±0.953
(0-2)
1.06±0.491
(0-8)
Controls Met/Met 20 1.15±0.460
(0-7)
0.25±0.123
(0-2)
0.2±0.092
(0-1)
0.25±0.143
(0-2)
Thr/Met 27 0.70±0.296
(0-6)
0.15±0.116
(0-3)
0.04±0.037
(0-1)
0.11±0.82
(0-2)
Thr/Thr 35 0.74±0.233
(0-6)
0.14±0.073
(0-2)
0.03±0.29
(0-1)
0.17±0.096
(0-2)
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Table 1 – Descriptive statistics for genotoxcity biomarkers means according to XRCC3 
Thr241Met polymorphisms
Figure 1 – Distribution of the genotoxcity biomarkers according to XRCC3 Thr241Met 
polymorphisms
